CYP 1.89% 27.0¢ cynata therapeutics limited

Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress, page-4

  1. 370 Posts.
    lightbulb Created with Sketch. 26
    Nothing new, it looks like a summary of past announcements apart from the fact that they reassured us that the trial is going all right.

    I reckon the first report may be available around September if everything goes to plan. Fun times ahead
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.